Events & Presentations
Upcoming Events
- Upcoming Events
- Archive
-
Nov 4, 2020Publication of the Interim Report for the first nine months 2020 (after 5:00 PM CET)Nov 13, 2020Genmab's Virtual Capital Markets Day
Genmab will host a virtual Capital Markets Day (CMD) for investors and analysts on Friday, 13 November, 2020.
The event will be webcast live from Genmab’s state-of-the-art R&D Center in Utrecht, the Netherlands, and from its new offices and laboratory facilities in Princeton, NJ, US. The CMD will feature Genmab’s Executive Management Team and a variety of high-level Genmab speakers. Additional details, including registration information, will be available closer to the date of the meeting.
Dec 31, 2020Financial calendar year end -
Sep 15, 2020 at 11:45 AM EDTMorgan Stanley 18th Annual Global Healthcare Conference
Fireside Chat with President and CEO, Jan van de Winkel and Executive Vice President and Chief Financial Officer, Anthony Pagano
Aug 26, 2020 at 4:30 PM CESTInteractive Q&A Session with Genmab's CEOAug 12, 2020Publication of the Interim Report for the first half 2020 (after 5:00 PM CEST)Jun 11, 2020 from 3:00 PM to 3:40 PM EDTGoldman Sachs 41st Annual Global Healthcare ConferenceFireside Chat with Executive Vice President and Chief Financial Officer, Anthony PaganoJun 10, 2020 from 1:00 PM to 2:00 PM CDTConference Call regarding Genmab and AbbVie PartnershipJun 2, 2020 from 8:30 AM to 8:55 AM EDTJefferies Virtual Healthcare Conference 2020Fireside chat with Genmab's President and CEO, Jan van de WinkelMay 11, 2020Interactive Q&A Session with Genmab's CEOMay 6, 2020Publication of the Interim Report for the first quarter 2020 (after 5:00 PM CET)May 6, 2020First Quarter 2020 Conference CallMar 26, 2020Annual General Meeting 2020Feb 26, 2020 at 2:30 PM CETInteractive Q&A Session with Genmab's CEOFeb 19, 2020 at 6:00 PM CET2019 Full Year Financial Results Conference CallFeb 19, 2020Publication of the Annual Report for 2019Feb 12, 2020Deadline for shareholders to submit any items for consideration for the agenda of the Annual General Meeting in writing to the Board of DirectorsJan 15, 2020 at 3:30 PM PST38th Annual J.P. Morgan Healthcare Conference, San Francisco, CA, USDec 31, 2019Financial calendar year endDec 9, 2019 at 8:00 PM EST2019 R&D Update and ASH Data ReviewNov 8, 2019 at 4:30 PM CETInteractive Q&A Session with Genmab’s CEONov 6, 2019 at 6:00 PM CETFirst Nine Months of 2019 Financial Results Conference CallNov 6, 2019Publication of the Interim Report for the first nine months 2019 (after 5:00 PM CET)Nov 6, 2019Publication of the Interim Report for the first nine months 2019 (after 5:00 PM CET)Aug 20, 2019 at 4:30 PM CESTInteractive Q&A Session with Genmab's CEOAug 14, 2019 at 6:00 PM CESTFirst Half 2019 Financial Results Conference CallAug 14, 2019Publication of the Interim Report for the first half 2019 (after 5:00 PM CEST)Jun 13 - Jun 16, 201924th European Hematology Association Annual Congress, Amsterdam, the NetherlandsMay 31 - Jun 4, 2019American Society of Clinical Oncology Annual Meeting, Chicago, IL, USMay 13, 2019 at 3:00 PM CESTInteractive Q&A Session with Genmab's Senior Director, Investor RelationsMay 8, 2019 at 6:00 PM CESTFirst Quarter 2019 Financial Results Conference CallMay 8, 2019 at 5:00 PM CESTPublication of the Interim Report for the first quarter 2019Mar 29, 2019Annual General Meeting 2019Mar 4, 2019 at 4:00 PM CETInteractive Q&A Session with Genmab's CEOFeb 20, 2019 at 6:00 PM CET2018 Full Year Financial Results Conference CallFeb 20, 2019 at 5:00 PM CETPublication of the Annual Report for 2018Feb 14, 2019Deadline for shareholders to submit any items for consideration for the agenda of the Annual General Meeting in writing to the Board of DirectorsJan 9, 2019 at 3:30 PM PST37th Annual J.P. Morgan Healthcare Conference, San Francisco, CA, USDec 31, 2018Financial calendar year end -
-